or
forgot password
  • cancer clinical trials in towson, MD

  • Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer
    St. Joseph Medical Center
    Towson, Maryland 21204
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter
    Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer
    Saint Joseph Medical Center, Cancer Care Program
    Towson, Maryland 21204
    Breast Cancer
    Surgery With or Without Internal Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
    Cancer Institute at St. Joseph Medical Center
    Towson, Maryland 21204
    Lung Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Saint Joseph Medical Center
    Towson, Maryland 21204
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Saint Joseph Medical Center
    Towson, Maryland 21204
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Saint Joseph Medical Center
    Towson, Maryland 21204
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    Cancer Institute at St. Joseph Medical Center
    Towson, Maryland 21204
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer
    Saint Joseph Medical Center, Cancer Care Program
    Towson, Maryland 21204
    Breast Cancer
    Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer
    Cancer Institute at St. Joseph Medical Center
    Towson, Maryland 21204
    Lung Cancer
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    Cancer Institute at St. Joseph Medical Center
    Towson, Maryland 21204
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    PEAK PlasmaBlade™ 4.0 Versus Traditional Electrosurgery in Mastectomy
    St. Joseph Medical Center
    Towson, Maryland 21204
    Mastectomy
    Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer
    University of Maryland Saint Joseph Medical Center
    Towson, Maryland 21204
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Endometrial Papillary Serous Carcinoma, Localized Unresectable Adult Primary Liver Cancer, Metastatic Gastrointestinal Carcinoid Tumor, Ovarian Carcinosarcoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Papillary Serous Carcinoma, Pancreatic Alpha Cell Adenoma, Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Adenoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Adenoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Adenoma, Pancreatic G-cell Carcinoma, Pancreatic Polypeptide Tumor, Pulmonary Carcinoid Tumor, Recurrent Adult Primary Liver Cancer, Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Cancer, Recurrent Gastrointestinal Carcinoid Tumor, Recurrent Islet Cell Carcinoma, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer, Regional Gastrointestinal Carcinoid Tumor, Stage IIIA Endometrial Carcinoma, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Endometrial Carcinoma, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Endometrial Carcinoma, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer, Stage IVA Endometrial Carcinoma, Stage IVB Endometrial Carcinoma, Uterine Carcinosarcoma
    Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer
    Saint Joseph Medical Center
    Towson, Maryland 21204
    Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
    Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 in Castration-Resistant Prostate Cancer (CRPC)
    Chesapeake Urology Research Associates
    Towson, Maryland 21204
    Prostate Cancer
    Selumetinib in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
    Saint Joseph Medical Center
    Towson, Maryland 21204
    Recurrent Adult Diffuse Large Cell Lymphoma
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    Chesapeake Urology Research Associates
    Towson, Maryland 21204
    Advanced Prostate Cancer, Prostatic Neoplasms
    Tivantinib in Treating Patients With Metastatic Prostate Cancer
    Saint Joseph Medical Center
    Towson, Maryland 21204
    Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    Cancer Symptom Data From Multiple Treatment Centers
    The Cancer Institute Catholic Health Initiatives
    Towson, Maryland 21204
    Breast Cancer, Colon Cancer
    Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
    Chesapeake Urology Research Assoc.
    Towson, Maryland 21204
    Prostate Cancer
    Clinical Trial in Males With BPH (Enlarged Prostate)
    Maryland Urology Association
    Towson, Maryland 21204
    Urinary Retention, Prostatic Hyperplasia, Benign Prostatic Hypertrophy
    Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin
    Endoscopic Microsurgery Associates
    Towson, Maryland
    Hepatitis C, Hepatitis C, Chronic
    A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients
    Central Maryland Oncology Group
    Towson, Maryland 21204
    Non-Small Cell Lung Cancer
    Non-small Cell Lung Cancer Registry
    St. Joseph Medical Center
    Towson, Maryland 21204
    Non-Small-Cell Lung Cancer, Pleural Effusion, Malignant
    Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By Surgery
    Cancer Institute at St. Joseph Medical Center
    Towson, Maryland 21204
    Colorectal Cancer
    Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer
    Chesapeake Urology Research Associates
    Towson, Maryland 21204
    Bladder Neoplasms
    Phase 3 Trial of Single-Dose Intravesical EOquin® as a Surgical Adjuvant for Noninvasive Bladder Cancer
    Chesapeake Urology Research Associates
    Towson, Maryland 21204
    Bladder Cancer
    Percutaneous Excision Trial
    St. Joseph Medical Center
    Towson, Maryland 21204
    Imaged Breast Abnormalities
    A Study of Degarelix in Patients With Prostate Cancer
    Chesapeake Urology Research Associates

    Trial Locations
    Chesapeake Urology Research Associates
    Chesapeake Urology Associates, PA
    Prostate Cancer